HEB, Hemispherx Biopharma (AMEX)NEW Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: MarcG who wrote (6)	11/6/1997 1:13:00 PM
From: Graham Marshman	Read Replies (1) of 857

This is looking real solid on all the TA and was real solid through the market dip this morning. It should keep going for a while. I agree with Marc that earnings, per se, are not what this is about; that's not 100% certain but only exceptional revenue from open label trials ongoing in Canada and Belgium could be significant. US is still restricted to 100 patients. Possible news items could be expansion of the US trial beyond 100 or a true Phase 3 trial (AMP-516) rather than the current open label. Another possibility is a trial for Hepatitis with the Beaufour Ipsen connection. Graham

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next